Recent advances in understanding the anti-diabetic actions of dietary flavonoids - PubMed (original) (raw)
Review
Recent advances in understanding the anti-diabetic actions of dietary flavonoids
Pon Velayutham Anandh Babu et al. J Nutr Biochem. 2013 Nov.
Abstract
Flavonoids are polyphenolic compounds that are abundant in fruits and vegetables, and increasing evidence demonstrates a positive relationship between consumption of flavonoid-rich foods and disease prevention. Epidemiological, in vitro and animal studies support the beneficial effects of dietary flavonoids on glucose and lipid homeostasis. It is encouraging that the beneficial effects of some flavonoids are at physiological concentrations and comparable to clinically-used anti-diabetic drugs; however, clinical research in this field and studies on the anti-diabetic effects of flavonoid metabolites are limited. Flavonoids act on various molecular targets and regulate different signaling pathways in pancreatic β-cells, hepatocytes, adipocytes and skeletal myofibers. Flavonoids may exert beneficial effects in diabetes by (i) enhancing insulin secretion and reducing apoptosis and promoting proliferation of pancreatic β-cells; (ii) improving hyperglycemia through regulation of glucose metabolism in hepatocytes; (iii) reducing insulin resistance, inflammation and oxidative stress in muscle and fat and (iv) increasing glucose uptake in skeletal muscle and white adipose tissue. This review highlights recent findings on the anti-diabetic effects of dietary flavonoids, including flavan-3-ols, flavanones, flavonols, anthocyanidins, flavones and isoflavones, with particular emphasis on the studies that investigated the cellular and molecular mechanisms involved in the beneficial effects of the compounds.
Keywords: ACC; AMPK; ATP; Acetyl Co-A carboxylase; Adenosine monophosphate-activated protein kinase; Adenosine triphosphate; BBE; BFE; Bayberry fruit extract; Bilberry extract; Carnitine palmitoyltransferase I; DM; Diabetes; Diabetes mellitus; ECG; EGC; EGCG; ER; Endoplasmic reticulum; Epicatechin gallate; Epigallocatechin; Epigallocatechin gallate; FFA; Flavonoids; FoXO1; Forkhead box protein O1; Free fatty acid; G6Pase; GK; GLUT; GSIS; Glucokinase; Glucose transporter; Glucose-6-phosphatase; Glucose-stimulated insulin secretion; HSP; Heat shock proteins; Hyperglycemia; IR; IRS; Insulin receptor; Insulin receptor substrate; Intraperitoneal; Islets; JNK; L-Cpt-1; MAPK; Mitogen activated protein kinase; NF-κB; NOD; Non-obese diabetic mice; Nuclear factor-κB; PDX-1; PEPCK; PGC-1α; PKC; PPAR; Pancreatic duodenal homeobox-1; Pancreatic β-cells; Peroxisome proliferator-activated receptor gamma coactivator-1-α; Phosphoenolpyruvate carboxykinase; Polyphenols; Protein kinase C; RBP4; RIN cells; ROS; Rat insulinoma cells; Reactive oxygen species; Retinol binding protein-4; STZ; Streptozotocin; T1D; T2D; TNFα; TZD; Thiazolidinedione; Tumor necrosis factor α; Type 1 diabetes mellitus; Type 2 diabetes mellitus; WAT; White adipose tissue; c-jun amino terminal kinase; cAMP; cyclic adenosine mono phosphate; i.p.; peroxisome proliferator activated receptor.
© 2013.
Figures
Figure
Dietary flavonoids exert their anti-diabetic effects by targeting various cellular signaling pathways in pancreas, liver, skeletal muscle, and white adipose tissues (⇧: Increase, ↓: Decrease, +: Stimulate).
Similar articles
- Novel insights of dietary polyphenols and obesity.
Wang S, Moustaid-Moussa N, Chen L, Mo H, Shastri A, Su R, Bapat P, Kwun I, Shen CL. Wang S, et al. J Nutr Biochem. 2014 Jan;25(1):1-18. doi: 10.1016/j.jnutbio.2013.09.001. J Nutr Biochem. 2014. PMID: 24314860 Free PMC article. Review. - Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management.
Tang G, Li S, Zhang C, Chen H, Wang N, Feng Y. Tang G, et al. Acta Pharm Sin B. 2021 Sep;11(9):2749-2767. doi: 10.1016/j.apsb.2020.12.020. Epub 2021 Feb 2. Acta Pharm Sin B. 2021. PMID: 34589395 Free PMC article. Review. - Cocoa flavonoids attenuate high glucose-induced insulin signalling blockade and modulate glucose uptake and production in human HepG2 cells.
Cordero-Herrera I, Martín MÁ, Goya L, Ramos S. Cordero-Herrera I, et al. Food Chem Toxicol. 2014 Feb;64:10-9. doi: 10.1016/j.fct.2013.11.014. Epub 2013 Nov 19. Food Chem Toxicol. 2014. PMID: 24262486 - Skeletal muscle salt inducible kinase 1 promotes insulin resistance in obesity.
Nixon M, Stewart-Fitzgibbon R, Fu J, Akhmedov D, Rajendran K, Mendoza-Rodriguez MG, Rivera-Molina YA, Gibson M, Berglund ED, Justice NJ, Berdeaux R. Nixon M, et al. Mol Metab. 2015 Nov 6;5(1):34-46. doi: 10.1016/j.molmet.2015.10.004. eCollection 2016 Jan. Mol Metab. 2015. PMID: 26844205 Free PMC article. - Dietary anthocyanin-rich bilberry extract ameliorates hyperglycemia and insulin sensitivity via activation of AMP-activated protein kinase in diabetic mice.
Takikawa M, Inoue S, Horio F, Tsuda T. Takikawa M, et al. J Nutr. 2010 Mar;140(3):527-33. doi: 10.3945/jn.109.118216. Epub 2010 Jan 20. J Nutr. 2010. PMID: 20089785
Cited by
- Polyphenol-rich diets improve glucose metabolism in people at high cardiometabolic risk: a controlled randomised intervention trial.
Bozzetto L, Annuzzi G, Pacini G, Costabile G, Vetrani C, Vitale M, Griffo E, Giacco A, De Natale C, Cocozza S, Della Pepa G, Tura A, Riccardi G, Rivellese AA. Bozzetto L, et al. Diabetologia. 2015 Jul;58(7):1551-60. doi: 10.1007/s00125-015-3592-x. Epub 2015 Apr 24. Diabetologia. 2015. PMID: 25906754 Clinical Trial. - Flavonoids and Mitochondria: Activation of Cytoprotective Pathways?
Kicinska A, Jarmuszkiewicz W. Kicinska A, et al. Molecules. 2020 Jul 4;25(13):3060. doi: 10.3390/molecules25133060. Molecules. 2020. PMID: 32635481 Free PMC article. Review. - De Novo Assembly of a Sarcocarp Transcriptome Set Identifies AaMYB1 as a Regulator of Anthocyanin Biosynthesis in Actinidia arguta var. purpurea.
Niu B, Li Q, Fan L, Shi X, Liu Y, Zhuang Q, Qin X. Niu B, et al. Int J Mol Sci. 2022 Oct 11;23(20):12120. doi: 10.3390/ijms232012120. Int J Mol Sci. 2022. PMID: 36292977 Free PMC article. - Flavonoids as Cytokine Modulators: A Possible Therapy for Inflammation-Related Diseases.
Leyva-López N, Gutierrez-Grijalva EP, Ambriz-Perez DL, Heredia JB. Leyva-López N, et al. Int J Mol Sci. 2016 Jun 9;17(6):921. doi: 10.3390/ijms17060921. Int J Mol Sci. 2016. PMID: 27294919 Free PMC article. Review.
References
- Philippe J, Raccah D. Treating type 2 diabetes: how safe are current therapeutic agents? Int J Clin Pract. 2009;63:321–332. - PubMed
- Akkati S, Sam KG, Tungha G. Emergence of promising therapies in diabetes mellitus. J Clin Pharmacol. 2011;51:796–804. - PubMed
- UnitedHealth Center for Health Reform & Modernization. The united states of diabetes: challenges and opportunities in the decade ahead. Working paper 5. 2010 Nov
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous